Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
46 巻, 9 号
選択された号の論文の21件中1~21を表示しています
ORIGINAL ARTICLES
  • Toshihiko Yamasa, Satoshi Ikeda, Seiji Koga, Eisuke Kawahara, Takahiro ...
    2007 年 46 巻 9 号 p. 543-546
    発行日: 2007年
    公開日: 2007/05/01
    ジャーナル オープンアクセス
    Background: Recently, the frequency of patients who have glucose intolerance has been increasing in Japan. Glucose intolerance and insulin resistance/hyperinsulinemia are thought to influence the progression of atherosclerosis. The present study examined glucose tolerance, insulin resistance, post-prandial hyperglycemia/hyperinsulinemia and coronary risk factors by using 75 g oral glucose tolerance test (OGTT).
    Patients and Methods: Coronary risk factors were examined and OGTT with measurement of plasma glucose and serum insulin was done to evaluate the glucose metabolism and insulin resistance in 263 patients who underwent coronary angiography; 202 subjects were diagnosed as having coronary heart disease (CHD) and 61 subjects were normal. We compared the two groups.
    Results: The rate of having diabetes was significantly high in the CHD group. From the result of OGTT, 22.3% of CHD patients had diabetes mellitus and 36.6% had impaired glucose tolerance, thus the total glucose intolerance rate was 57.7% in the CHD group. No significant difference was noted in the homeostatic model assessment-R (HOMA-R), but glucose and insulin at 2 hours after OGTT were all significantly high in the CHD group.
    Conclusion: The rate of glucose intolerance and the levels of post-prandial glucose and insulin were high in the CHD group. We concluded that the post-prandial hyperglycemia and hyperinsulinemia influenced the incidence of CHD.
  • Nariko Ohmori, Megumi Miyakawa, Kazue Ohmori, Kazue Takano
    2007 年 46 巻 9 号 p. 547-550
    発行日: 2007年
    公開日: 2007/05/01
    ジャーナル オープンアクセス
    Objective: Papillary thyroid carcinoma (PTC) sometimes occurs with Hashimoto's thyroiditis (HT). It is often difficult to differentiate between benign and malignant nodules in HT because HT varies greatly on ultrasonography. We aimed to characterize the ultrasonographic features of PTC with HT.
    Patients and Methods: In this retrospective study, 2167 patient records (1897 women and 270 men) were examined for ultrasonographic features and thyroid autoantibodies between 1998 and 2002 at our university. Patients with Graves' disease, positive TSH receptor autoantibody (TRAb) or thyroid-stimulating antibody (TSAb) were excluded. PTC was diagnosed by pathological examination.
    Results: Of the 1644 patients who were autoantibody negative (MCHA, TGHA, TgAb, TPOAb), 54 (3.3%) had PTC, while 29 (5.5%) of the 523 patients who were autoantibody positive had PTC. On ultrasonography, the frequency of dense calcification in patients with HT was significantly higher (P=0.0064) and frequency of psammoma bodies was less than PTC patients without HT (P<0.0001). On the other hand, PTC with HT had more irregular shapes and ill-defined edges of the borders with less hypoechogenecity and calcification than PTC without HT, but the difference was not significant.
    Conclusion: The frequency of psammoma bodies in PTC with HT was less, while dense calcifications were greater than in those of PTC without HT. Any type of ultrasonographic calcification features may represent a risk for PTC.
  • Masayoshi Masuko, Masahiro Ito, Tori Kurasaki, Toshio Yano, Jun Takiza ...
    2007 年 46 巻 9 号 p. 551-555
    発行日: 2007年
    公開日: 2007/05/01
    ジャーナル オープンアクセス
    Objective: Cardiovascular complication is one of the serious complications in stem cell transplantation (SCT). We measured plasma brain natriuretic peptide (BNP) concentrations in patients who received SCT to evaluate possible cardiac toxicity of the regimens employed in SCT.
    Patients: Ten patients with allogeneic SCT and 5 patients with autologous SCT using myeloablative conditioning regimens were enrolled. The preparative chemotherapy for 8 patients with allogeneic SCT included cyclophosphamide (60 mg/kg i.v. for 2 days) and other drugs and that for autologous SCT included cyclophosphamide (50 mg/kg for 2 days) and other drugs. Total body irradiation (TBI) was employed only in the patients who received allogeneic SCT.
    Method: Plasma BNP was measured using a radioimmunoassay for human BNP before and after SCT.
    Results: In 13 of 15 patients, BNP levels were elevated after SCT. In patients who received a total body irradiation (TBI) of 13.2 Gy, BNP levels were higher than those without irradiation (p=0.01). The BNP level reached a peak within 6 months after SCT in most patients and fell thereafter. But 7 of the 15 patients (46.7%) had an abnormally high level of plasma BNP even after 6 months of SCT which suggests subclinical myocardial damage.
    Conclusion: A rise in plasma BNP was frequently observed after SCT, and may be considered to represent cardiac damage caused by the preparative chemotherapy and/or total body irradiation. Since a rise was noted 6 months after SCT, long-term evaluation of cardiac function is important.
  • Nobuo Wakata, Hiroshi Nemoto, Shinngo Konno, Hiroshi Nakazora, Nobuats ...
    2007 年 46 巻 9 号 p. 557-559
    発行日: 2007年
    公開日: 2007/05/01
    ジャーナル オープンアクセス
    Background: The most common treatment of myasthenia gravis is high-dose prednisolone administration and thymectomy. A well-known adverse effect of prednisolone is hyperglycemia, however, to date there is no such detailed report.
    Patients and Methods: We treated 325 myasthenia gravis patients in a recent 35 years period, and found 11 patients with diabetes mellitus. We compared these 11 diabetic patients with previously-reported cases.
    Results: These 11 patients did not have any antibody against β-cells in the pancreas such as anti-glutamic acid decarboxylase antibody. In 10 of 11 patients diabetes mellitus was controlled with oral medications.
    Conclusion: Myasthenic patients with diabetes mellitus could be classified into 2 groups, one group with positive organ-specific autoantibodies to many organs (with type 1 diabetes mellitus), and the other group with diabetes mellitus onset during prednisolone administration (with type 2 diabetes mellitus).
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
feedback
Top